TKD
Showing 1 - 25 of 47
AML, Adult, Refractory AML, Relapsed Adult AML Trial in France (AzaCITIDine Oral Tablet, Xospata)
Not yet recruiting
- AML, Adult
- +4 more
- AzaCITIDine Oral Tablet
- Xospata
-
Amiens, France
- +19 more
Sep 1, 2023
FLT3-ITD Mutation, FLT3/TKD Mutation, PDGFR-Alpha D842V Trial in Genova (Crenolanib besylate)
Available
- FLT3-ITD Mutation
- +3 more
- Crenolanib besylate
-
Genova, ItalyOspedale Policlinico San Martino
May 21, 2020
Anorexia Nervosa in Remission Trial in San Diego (Therapeutic Ketogenic Diet)
Not yet recruiting
- Anorexia Nervosa in Remission
- Therapeutic Ketogenic Diet
-
San Diego, CaliforniaUniversity of California San Diego
Aug 14, 2023
Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD) Trial in
No longer available
- Acute Myeloid Leukemia (AML) With
- FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD)
-
Phoenix, Arizona
- +43 more
Jul 14, 2020
AML, Adult Trial in Berne (HDM201, Midostaurin)
Terminated
- AML, Adult
-
Berne, SwitzerlandDepartement of Medical Oncology, University Hospital Berne
Oct 3, 2022
Acute Myeloid Leukemia Trial in United States (Gilteritinib, Midostaurin, Daunorubicin)
Active, not recruiting
- Acute Myeloid Leukemia
- Gilteritinib
- +3 more
-
Scottsdale, Arizona
- +43 more
Nov 17, 2022
GilteRInf 2022 Study (Gilteritinib Related Infections)
Active, not recruiting
- Acute Myeloid Leukemia
-
Roma, RM, ItalyMaria Ilaria Del Principe
Mar 17, 2023
Acute Myeloid Leukemia With KMT2A Rearrangement, Acute Myeloid Leukemia With NPM1 Mutation Trial (Biospecimen Collection, Bone
Not yet recruiting
- Acute Myeloid Leukemia With KMT2A Rearrangement
- Acute Myeloid Leukemia With NPM1 Mutation
- Biospecimen Collection
- +7 more
- (no location specified)
Jun 1, 2023
Acute Myeloid Leukemia With FLT3/ITD Mutation Trial in Tampa (Gilteritinib, Vyxeos)
Suspended
- Acute Myeloid Leukemia With FLT3/ITD Mutation
-
Tampa, FloridaMoffitt Cancer Center
Nov 11, 2022
Urinary Retention Trial in Istanbul (Modified Supine Position)
Not yet recruiting
- Urinary Retention
- Modified Supine Position
-
Istanbul, TurkeyBasaksehir Cam ve Sakura City Hospital
Sep 30, 2023
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Mixed-Phenotype Leukemia Trial in United States (BMF-500)
Not yet recruiting
- Acute Myeloid Leukemia
- +2 more
-
Los Angeles, California
- +9 more
Jun 27, 2023
Cardiac Amyloidosis Trial in Izmir (Algorithm)
Recruiting
- Cardiac Amyloidosis
- Algorithm
-
Izmir, TurkeyDokuz Eylul University Faculty of Medicine
May 31, 2021
Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11,
Active, not recruiting
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- +5 more
- Biopsy
- +7 more
-
Lewes, Delaware
- +42 more
Mar 15, 2022
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias
Recruiting
- Leukemia
-
Vienna, AustriaMedical Universitiy of Vienna
Mar 23, 2021
Italian Non-Interventional Study of FLT3 Mutated AML Patients
Unknown status
- AML
- +2 more
- Clinical and Molecular data collection
-
Ancona, AN, Italy
- +32 more
Apr 20, 2020
FLT3-ITD Gene Mutation and CD135 Expression in Acute Myeloid
Not yet recruiting
- Acute Myeloid Leukemia
- (no location specified)
May 17, 2022
Atrial Fibrillation Trial in Kahramanmaras (How Important Is Acupress Applying In Atrial Fibrilation Treatment?)
Completed
- Atrial Fibrillation
- How Important Is Acupress Applyıng In Atrıal Fıbrılatıon Treatment?
-
Kahramanmaras, TurkeyKahramanmarasSIU
Apr 24, 2022
Proprioceptive Disorders Trial in Madrid (Strength and proprioception exercises)
Withdrawn
- Proprioceptive Disorders
- Strength and proprioception exercises
-
Madrid, Comunity Of Madrid, SpainUniversidad Europea de Madrid
Sep 1, 2021
NSCLC Stage IIIA/B Trial in Munich (Hsp70-peptide TKD/IL-2 activated, autologous NK cells)
Suspended
- NSCLC Stage IIIA/B
- Hsp70-peptide TKD/IL-2 activated, autologous NK cells
-
Munich, GermanyKlinikum rechts der Isar, Strahlentherapie und Radiologische Onk
Jan 14, 2019
Acute Myelogenous Leukemia (AML) Trial in Australia (MAX-40279)
Recruiting
- Acute Myelogenous Leukemia (AML)
-
Darlinghurst, New South Wales, Australia
- +3 more
Jan 18, 2022
Acute Myeloid Leukemia Trial (Gilteritinib 40 MG Oral Tablet, Cladribine, Cytarabine)
Not yet recruiting
- Acute Myeloid Leukemia
- Gilteritinib 40 MG Oral Tablet
- +4 more
-
Lexington, KentuckyUniversity of Kentucky
Oct 27, 2022
New Cytokine-based Dynamic Stratification Based on FLt3 Ligand
Recruiting
- Acute Myeloid Leukemia
- No intervention
-
Strasbourg, Bas-Rhin, France
- +24 more
Aug 25, 2021